Georgia CaRes

佐治亚州卡雷斯

• 批准号: 9321314
• 负责人: Sharad A. Ghamande
• 金额: $ 70.58万
• 依托单位: AUGUSTA UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9321314
• 关键词: Affect; African American; Area; Behavioral; Cancer Center; Cancer Prevention Trial; Caring; Caucasians; Clinical Oncology; Clinical Trials; Colorectal Cancer; Communication; Communities; Community Clinical Oncology Program; Country; Diagnosis; Disease; Enrollment; Ensure; Feedback; Geography; Glare; Health; Health Sciences; Health Services; Hematopoietic Neoplasms; Home environment; Image; Institutes; Institution; Knowledge; Leadership; Malignant Neoplasms; Malignant neoplasm of prostate; Mentors; Minority; Morehouse School of Medicine; Oncologist; Patients; Prevention; Prevention Research; Prevention trial; Preventive; Primary Health Care; Program Development; Protocols documentation; Provider; Public Health; Public Health Practice; Research; Research Design; Research Personnel; Rural Health; Rural Population; Scientist; Site; Specialist; Structure; Time; Translating; Translational Research; Translations; Underserved Population; Universities; Urban Population; Woman; anticancer research; base; cancer care; cancer health disparity; cancer prevention; cancer therapy; care delivery; clinical practice; college; control trial; design; health disparity; institutional capacity; interest; leadership development; male; malignant breast neoplasm; medical schools; medically underserved; men; multidisciplinary; next generation; oncology program; programs; research study; rural counties; rural setting; screening; treatment trial; underserved minority; urban setting; working group

DESCRIPTION (provided by applicant): Georgia Regents University (GRU) has been home to Georgia's only NCI MB-CCOP since 2004. With its affiliate site, University Cancer & Blood Center (UCBC), GRU has enrolled nearly 800 patients to NCI clinical trials: 39% of them African American (AA) and other minorities, with accrual split between treatment trials (48%) and prevention and control trials (52%). Building on this successful track record, GRU Cancer Center (GRUCC) and UCBC are joining forces with Morehouse School of Medicine (MSM) and the Jiann-Ping Hsu College of Public Health (JPHCOPH) at Georgia Southern University to become the NCORP Minority/Underserved Community Site for Georgia. The need to sustain and grow an NCORP that focuses on minority and underserved populations in Georgia is great. Georgia has some of the nation's worst cancer disparities, particularity between African Americans (AA) and Caucasians (CA) and between rural and urban populations. The disparities are glaring for some of the most common cancers. Not only do AA men in Georgia have the highest rate of prostate cancer among AA men in the country, they are almost twice as likely to be diagnosed with the disease as CA men in Georgia and three times as likely to die from it. In Georgia, AA women die of breast cancer 25% more often than CA women, and AA die of colorectal cancer 45% more than CA. The Specific Aims of the proposed NCORP M/U site for Georgia are to: 1) Implement a NCORP M/U Site for Georgia that meets or exceeds all NCI requirements; 2) Contribute to the design, conduct and translation of the national NCORP research agenda, particularity studies that pertain to minority and underserved populations; and 3) expand patient and provider access to-and enrollment/participation in-cancer prevention, control, imaging, treatment and screening/post-surveillance clinical trials and cancer care delivery research throughout Georgia, particularly for minority and underserved populations in urban and rural settings. Key sub-aims include the implementation of a leadership development program to cultivate the next generation of NCORP investigators and leaders and engagement to key stakeholders and community partners in all aspects of the NCORP research agenda.

描述（由申请人提供）：佐治亚摄政大学 (GRU) 自 2004 年以来一直是佐治亚州唯一的 NCI MB-CCOP 的所在地。GRU 凭借其附属机构大学癌症与血液中心 (UCBC)，已招募了近 800 名患者参加 NCI 临床试验：其中 39% 为非裔美国人 (AA) 和其他少数族裔，应计费用分为治疗试验 (48%) 和预防和控制试验 (52%)。在此成功记录的基础上，GRU 癌症中心 (GRUCC) 和 UCBC 与莫尔豪斯医学院 (MSM) 和佐治亚南方大学徐建平公共卫生学院 (JPHCOPH) 联手，成为佐治亚州 NCORP 少数族裔/服务不足的社区站点。维持和发展专注于佐治亚州少数民族和服务不足人口的 NCORP 的需求非常大。佐治亚州的癌症差异是全国最严重的，尤其是非裔美国人 (AA) 和白种人 (CA) 以及农村和城市人口之间的差异。对于一些最常见的癌症来说，差异非常明显。佐治亚州的 AA 男性不仅是该国 AA 男性中前列腺癌发病率最高的，而且他们被诊断出患有该疾病的可能性几乎是佐治亚州的 CA 男性的两倍，死于该病的可能性是佐治亚州的三倍。在佐治亚州，AA 女性死于乳腺癌的几率比 CA 女性高 25%，AA 女性死于结直肠癌的几率比 CA 女性高 45%。拟议的乔治亚州 NCORP M/U 站点的具体目标是： 1) 为乔治亚州实施满足或超过所有 NCI 要求的 NCORP M/U 站点； 2) 为国家 NCORP 研究议程、与少数群体和服务不足人群有关的特殊性研究的设计、实施和翻译做出贡献； 3) 扩大患者和提供者在整个佐治亚州的癌症预防、控制、成像、治疗和筛查/监测后临床试验和癌症护理提供研究的获取和登记/参与，特别是针对城乡环境中的少数民族和服务不足的人群。主要子目标包括实施领导力发展计划，以培养下一代 NCORP 研究人员和领导者，以及让主要利益相关者和社区合作伙伴参与 NCORP 研究议程的各个方面。